Immuneering Operating Income vs Interest Income Analysis

IMRX Stock  USD 1.86  0.04  2.20%   
Immuneering Corp financial indicator trend analysis is infinitely more than just investigating Immuneering Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immuneering Corp is a good investment. Please check the relationship between Immuneering Corp Operating Income and its Interest Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.

Operating Income vs Interest Income

Operating Income vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immuneering Corp Operating Income account and Interest Income. At this time, the significance of the direction appears to have pay attention.
The correlation between Immuneering Corp's Operating Income and Interest Income is -0.87. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Interest Income in the same time period over historical financial statements of Immuneering Corp, assuming nothing else is changed. The correlation between historical values of Immuneering Corp's Operating Income and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Immuneering Corp are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Operating Income i.e., Immuneering Corp's Operating Income and Interest Income go up and down completely randomly.

Correlation Coefficient

-0.87
Relationship DirectionNegative 
Relationship StrengthSignificant

Operating Income

Operating Income is the amount of profit realized from Immuneering Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Immuneering Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.
Most indicators from Immuneering Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immuneering Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.At this time, Immuneering Corp's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 46.53 in 2025, whereas Selling General Administrative is likely to drop slightly above 10.2 M in 2025.
 2022 2023 2024 2025 (projected)
Total Operating Expenses51.9M57.6M66.3M37.3M
Cost Of Revenue158.1K764.1K687.7K732.6K

Immuneering Corp fundamental ratios Correlations

-0.810.910.910.980.970.98-0.96-0.810.850.980.970.711.0-0.490.950.62-0.580.94-0.72-0.380.980.631.00.940.44
-0.81-0.8-0.84-0.7-0.71-0.810.930.78-0.89-0.89-0.79-0.69-0.810.21-0.77-0.60.11-0.780.41-0.16-0.7-0.67-0.81-0.77-0.44
0.91-0.80.990.910.940.98-0.89-0.940.90.940.980.870.89-0.680.990.82-0.631.0-0.44-0.440.910.810.91.00.6
0.91-0.840.990.90.920.97-0.92-0.940.950.960.980.880.9-0.650.980.79-0.580.99-0.47-0.360.90.790.90.980.57
0.98-0.70.910.90.990.97-0.9-0.80.80.940.970.70.98-0.590.960.62-0.710.94-0.73-0.541.00.610.980.950.42
0.97-0.710.940.920.990.98-0.9-0.820.810.940.980.730.97-0.610.980.67-0.710.97-0.67-0.550.990.650.970.970.46
0.98-0.810.980.970.970.98-0.95-0.890.90.981.00.810.97-0.620.990.73-0.640.99-0.61-0.440.970.720.970.990.51
-0.960.93-0.89-0.92-0.9-0.9-0.950.84-0.92-0.99-0.93-0.74-0.960.42-0.91-0.590.42-0.910.640.17-0.9-0.66-0.96-0.9-0.39
-0.810.78-0.94-0.94-0.8-0.82-0.890.84-0.89-0.86-0.9-0.97-0.790.75-0.89-0.840.61-0.930.230.36-0.8-0.93-0.79-0.92-0.63
0.85-0.890.90.950.80.810.9-0.92-0.890.930.890.830.83-0.550.890.67-0.410.9-0.47-0.160.80.70.840.880.49
0.98-0.890.940.960.940.940.98-0.99-0.860.930.970.770.98-0.50.950.67-0.510.95-0.64-0.280.940.690.980.950.48
0.97-0.790.980.980.970.981.0-0.93-0.90.890.970.820.96-0.651.00.74-0.670.99-0.59-0.470.970.740.960.990.53
0.71-0.690.870.880.70.730.81-0.74-0.970.830.770.820.68-0.810.810.88-0.620.85-0.09-0.380.70.960.690.850.73
1.0-0.810.890.90.980.970.97-0.96-0.790.830.980.960.68-0.460.940.6-0.560.92-0.74-0.360.980.611.00.920.42
-0.490.21-0.68-0.65-0.59-0.61-0.620.420.75-0.55-0.5-0.65-0.81-0.46-0.66-0.670.9-0.690.090.79-0.59-0.7-0.47-0.69-0.53
0.95-0.770.990.980.960.980.99-0.91-0.890.890.951.00.810.94-0.660.75-0.681.0-0.57-0.50.960.730.941.00.53
0.62-0.60.820.790.620.670.73-0.59-0.840.670.670.740.880.6-0.670.75-0.530.790.03-0.350.620.920.60.80.92
-0.580.11-0.63-0.58-0.71-0.71-0.640.420.61-0.41-0.51-0.67-0.62-0.560.9-0.68-0.53-0.670.370.95-0.71-0.52-0.57-0.68-0.39
0.94-0.781.00.990.940.970.99-0.91-0.930.90.950.990.850.92-0.691.00.79-0.67-0.51-0.480.940.770.921.00.57
-0.720.41-0.44-0.47-0.73-0.67-0.610.640.23-0.47-0.64-0.59-0.09-0.740.09-0.570.030.37-0.510.31-0.730.06-0.74-0.510.14
-0.38-0.16-0.44-0.36-0.54-0.55-0.440.170.36-0.16-0.28-0.47-0.38-0.360.79-0.5-0.350.95-0.480.31-0.54-0.28-0.36-0.49-0.23
0.98-0.70.910.91.00.990.97-0.9-0.80.80.940.970.70.98-0.590.960.62-0.710.94-0.73-0.540.610.980.950.42
0.63-0.670.810.790.610.650.72-0.66-0.930.70.690.740.960.61-0.70.730.92-0.520.770.06-0.280.610.610.780.78
1.0-0.810.90.90.980.970.97-0.96-0.790.840.980.960.691.0-0.470.940.6-0.570.92-0.74-0.360.980.610.930.42
0.94-0.771.00.980.950.970.99-0.9-0.920.880.950.990.850.92-0.691.00.8-0.681.0-0.51-0.490.950.780.930.58
0.44-0.440.60.570.420.460.51-0.39-0.630.490.480.530.730.42-0.530.530.92-0.390.570.14-0.230.420.780.420.58
Click cells to compare fundamentals

Immuneering Corp Account Relationship Matchups

Immuneering Corp fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets38.4M166.7M122.4M102.6M118.0M97.7M
Short Long Term Debt Total621.1K5.4M4.8M4.5M4.0M5.1M
Other Current Liab699.0K4.0M4.5M5.4M6.2M3.3M
Total Current Liabilities2.3M5.6M8.1M7.8M9.0M5.3M
Total Stockholder Equity(22.5M)156.0M109.9M90.6M104.2M72.0M
Property Plant And Equipment Net677.5K6.1M5.8M5.4M6.2M4.0M
Net Debt(36.5M)(69.5M)(67.8M)(54.9M)(49.4M)(51.9M)
Retained Earnings(25.7M)(59.3M)(109.8M)(163.3M)(146.9M)(139.6M)
Accounts Payable1.5M1.4M3.2M2.1M2.4M1.9M
Cash37.1M74.9M72.6M59.4M68.3M56.7M
Non Current Assets Total691.8K14.4M13.6M13.5M15.5M9.3M
Non Currrent Assets Other(31.9K)102.1K743.7K1.0M1.2M1.2M
Cash And Short Term Investments37.1M149.2M105.5M85.7M98.5M86.1M
Liabilities And Stockholders Equity38.4M166.7M122.4M102.6M118.0M97.7M
Non Current Liabilities Total58.6M5.1M4.5M4.2M3.7M3.6M
Capital Lease Obligations621.1K5.4M4.8M4.5M5.1M3.4M
Other Current Assets141.0K2.9M3.2M3.4M3.9M2.1M
Other Stockholder Equity61.4M(166.5B)(122.1B)253.8M228.4M239.8M
Total Liab60.9M10.7M12.5M12.0M10.8M18.7M
Net Invested Capital(22.5M)156.0M109.9M90.6M104.2M72.0M
Property Plant And Equipment Gross677.5K807.2K1.4M6.1M7.0M7.4M
Total Current Assets37.7M152.3M108.7M89.1M102.4M88.4M
Accumulated Other Comprehensive Income(58.1M)(49.0K)(30.1K)(778.0)(894.7)(939.43)
Net Working Capital35.5M146.7M100.7M81.2M93.4M83.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immuneering Stock Analysis

When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.